Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Best of ASCO® Miami 2017 /
Current and future prospects in treating multiple myeloma

14th - 16th Jul 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.07.17
Views: 1095

Dr Sergio Giralt – Cornell University, New York, USA

Dr Giralt speaks with ecancer at the Best of ASCO meeting in Miami to discuss current and future prospect in treating multiple myeloma.

He outlines the changing understanding of myeloma as a family of diseases, and emerging treatment choices including different staging and combinations of IMID and bortezomib based therapy.

Dr Giralt also highlights the new therapeutic options of immune modulatory therapy, and calls for widening access to trials and treatments.

Advances in haematology were also discussed by Dr José Sandoval here.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation